Anfield Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-667	Closed	-$16.9K	–	91
2022 Q4	$16.9K	Sell	667 -123	-16%	-$3.11K	0.01%	81
2022 Q3	$15K	Buy	790 +28	+4%	+$532	0.01%	87
2022 Q2	$19K	Buy	762 +112	+17%	+$2.79K	0.01%	90
2022 Q1	$17K	Buy	+650	New	+$17K	0.01%	94